[Hypoglycemia during treatment with a beta blockader].
D000273:Adipose Tissue / Q000378:metabolism; D002395:Catecholamines / Q000502:physiology; D000242:Cyclic AMP / Q000096:biosynthesis; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000378:metabolism; D010869:Pindolol / Q000009:adverse effects* / Q000627:therapeutic use
D002395:Catecholamines; D007328:Insulin; D008112:Liver Glycogen; D010869:Pindolol; D000242:Cyclic AMP
Hypoglycémie au cours d'un traitement béta bloqueur